Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

33.1K
Overview
33.1K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

92
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
92
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

80
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Antibody Structure01:10

Antibody Structure

66.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
66.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal Diabetes and Subsequent Risk of Asthma and Atopic Dermatitis in Offspring: A Binational Birth Cohort Study in South Korea and Japan.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Circulating immune complexes in dogs with Leishmania infantum infection in a non-endemic country.

PloS one·2026
Same author

Sensitization to Blomia tropicalis Across Climatic Zones: A Comparison Between Mediterranean and Tropical Regions.

Journal of investigational allergology & clinical immunology·2026
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy·2026
Same author

Global Prevalence of Sexual Dysfunction in Individuals With Atopic Dermatitis and Asthma: A Systematic Review and Meta-Analysis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Revealing the Complexity of Allergies in Spain: A Multicenter Study on Sensitization Patterns and Clinical Implications.

Journal of investigational allergology & clinical immunology·2026

Related Experiment Video

Updated: Mar 6, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K

Mite allergen extracts and clinical practice.

Jerónimo Carnés1, Víctor Iraola1, Seong H Cho2

  • 1Research & Development Department, Laboratorios LETI, Madrid, Spain.

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|March 13, 2017
PubMed
Summary
This summary is machine-generated.

Manufacturing processes for mite allergen extracts significantly impact their final composition and potency. Understanding these processes and standardization methods is crucial for effective diagnosis and treatment of house dust mite allergies.

More Related Videos

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.0K
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

17.0K

Related Experiment Videos

Last Updated: Mar 6, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.0K
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

17.0K

Area of Science:

  • Allergy and Immunology
  • Biotechnology
  • Manufacturing Science

Background:

  • House dust mites, particularly Dermatophagoides farinae and Dermatophagoides pteronyssinus, are primary triggers for allergic sensitization and symptoms.
  • Storage mites and other indoor mite allergens also contribute to allergic conditions in susceptible individuals.
  • Current treatment limitations highlight the need for effective diagnostic and therapeutic tools.

Purpose of the Study:

  • To elucidate the manufacturing processes of mite source materials and allergen extracts.
  • To identify critical process parameters influencing the composition of allergenic extracts.
  • To inform healthcare professionals about factors affecting mite extract quality and potency.

Main Methods:

  • Literature review including PubMed searches with targeted keywords.
  • Analysis of relevant regulatory documents and industry guidelines.
  • Integration of published data with authors' expertise and practical experience.

Main Results:

  • Mite cultivation and purification are critical for the final composition of allergen extracts.
  • Standardization approaches differ between the US (total allergenic activity) and Europe (in-house/international standards).
  • Variability in manufacturing and standardization can affect extract quality and potency.

Conclusions:

  • Differences in mite extract manufacturing and standardization can lead to variations in quality and potency.
  • Healthcare providers must be aware of potential sources of variability in mite allergen extracts.
  • Well-standardized house dust mite extracts are essential for successful diagnosis and treatment of related allergies.